Sevenfact®, an approved coagulation factor VIIa (recombinant) that is available for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors. Sevenfact® is available through a joint venture with US Worldmeds, HEMA Biologics.